Join today and have your say! It’s FREE!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}

Join today with :


By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Sign in with existing account
Please Try Again
{{ error }}

Sign In With :


Password Hint : {{passwordHint}}
Forgot Password?
Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Obalon Therapeutics Inc. OBLN

"Obalon Therapeutics Inc is a medical device company that focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss."

View modes: 

still holding this stock

this one was on my watch list,but I have a marker for alerts for price changes up or down,so there was no screener this time because it's my second time around glta.  rate and reply

RE:it's picking up

Which stock scanners are you using?  rate and reply

Former Health Canada Senior Regulatory Compliance Officer joins Nextleaf

"The serious regulatory infractions by several large Canadian licensed cannabis producers, along with an expanded scope of cannabis products through legalization 2.0, reinforces the critical role that compliance oversight plays in building a cannabis company all stakeholders can be proud of," stated Paul Pedersen, co-founder and CEO of Nextleaf Solutions. "Sherry is more

it's picking up

in price,so glta shareholders.  rate and reply

it's a buy today for me

got back into this one again,playing it again,so glta.  rate and reply

it's a sell today for me

got out at lunchtime,it was at $1.23 per share,great day trade for me,so glta.  rate and reply

it's a buy today for me

big purchase for me this morning at .87 cents per share,so glta.  rate and reply


Get our FREE StockTalk Investor Guides by sector as they are released!

Stay on top of sector specific news, get industry leaders insights and our best content, delivered to your email.

You are already a member! Please enter your password to sign in.